Holen Sie sich die Stockscreener-App
18.54
0.75%
-0.14
Vorhandelsmarkt:
18.74
0.20
+1.08%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BAX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$18.68
Offen:
$18.53
24-Stunden-Volumen:
4.59M
Relative Volume:
0.56
Marktkapitalisierung:
$9.58B
Einnahmen:
$11.32B
Nettoeinkommen (Verlust:
$-981.00M
KGV:
-9.4921
EPS:
-1.9532
Netto-Cashflow:
$714.00M
1W Leistung:
-4.09%
1M Leistung:
+7.73%
6M Leistung:
-1.85%
1J Leistung:
-38.38%
1-Tages-Spanne:
$18.42
$18.86
1-Wochen-Bereich:
$18.11
$19.31
52-Wochen-Spanne:
$15.73
$32.04
Baxter International Inc Stock (BAX) Company Profile
Firmenname
Baxter International Inc
Sektor
Telefon
(224) 948-2000
Adresse
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
18.54 | 9.65B | 11.32B | -981.00M | 714.00M | -1.9532 |
ISRG
Intuitive Surgical Inc
|
407.29 | 142.48B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
145.61 | 39.80B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
64.22 | 31.35B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
34.47 | 28.07B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
186.46 | 26.52B | 5.54B | 1.52B | 1.74B | 10.37 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-31 | Herabstufung | Argus | Buy → Hold |
| 2025-08-04 | Herabstufung | Stifel | Buy → Hold |
| 2025-08-01 | Herabstufung | Goldman | Buy → Neutral |
| 2025-02-26 | Fortgesetzt | Goldman | Buy |
| 2025-02-24 | Hochstufung | Argus | Hold → Buy |
| 2025-02-20 | Fortgesetzt | Barclays | Overweight |
| 2024-07-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-10 | Herabstufung | TD Cowen | Buy → Hold |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-12-19 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-12-15 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-12-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-06-24 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Herabstufung | Goldman | Neutral → Sell |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-18 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | Bestätigt | Morgan Stanley | Overweight |
| 2022-02-18 | Bestätigt | Raymond James | Outperform |
| 2022-02-18 | Bestätigt | Stifel | Buy |
| 2022-02-18 | Bestätigt | UBS | Neutral |
| 2022-02-18 | Bestätigt | Wells Fargo | Overweight |
| 2022-02-11 | Eingeleitet | Goldman | Neutral |
| 2022-01-07 | Fortgesetzt | Citigroup | Buy |
| 2022-01-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | Hochstufung | Cowen | Market Perform → Outperform |
| 2021-09-03 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-05-25 | Eingeleitet | Barclays | Equal Weight |
| 2021-01-29 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | Herabstufung | UBS | Buy → Neutral |
| 2020-12-15 | Herabstufung | Goldman | Buy → Neutral |
| 2020-10-01 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-09-04 | Herabstufung | Argus | Buy → Hold |
| 2020-06-24 | Eingeleitet | Oppenheimer | Outperform |
| 2020-03-19 | Hochstufung | Stifel | Hold → Buy |
| 2020-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-02 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-12-17 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-01-02 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-01-02 | Hochstufung | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | Hochstufung | Argus | Hold → Buy |
| 2018-10-16 | Eingeleitet | Barclays | Underweight |
| 2018-05-17 | Fortgesetzt | Piper Jaffray | Overweight |
| 2018-02-06 | Bestätigt | Citigroup | Neutral |
| 2018-01-03 | Eingeleitet | Evercore ISI | Outperform |
| 2018-01-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
Alle ansehen
Baxter International Inc Aktie (BAX) Neueste Nachrichten
Baxter (BAX) interim CFO Anita Zielinski receives 13,426-share equity grant - Stock Titan
Baxter (BAX) surgery president forfeits shares to cover RSU tax bill - Stock Titan
Baxter (BAX) executive forfeits 321 shares to cover RSU tax withholding - Stock Titan
Baxter Introduces IV Verify Line Labeling System - Medical Product Outsourcing
Baxter Highlights Recent Sustainable Activities and Recognition - CSRwire
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Baxter International Inc. stock (US0673431090): Shares ease around USD 18 after recent earnings and - AD HOC NEWS
Baxter International Inc. stock underperforms Monday when compared to competitors - MarketWatch
Baxter International Inc. (BAX) Stock Analysis: Navigating the Healthcare Sector with a 14.71% Potential Upside - DirectorsTalk Interviews
Baxter International Inc. stock (US0673431090): shares steady on NYSE as investors watch technical s - AD HOC NEWS
Baxter and Its Foundation Contribute Nearly $44 Million in 2008 to Address Critical Needs Locally and Globally - CSRwire
Baxter International Inc. stock (US0673431090): shares trade near lower end of 52-week range on NYSE - AD HOC NEWS
Baxter International Inc. stock underperforms Friday when compared to competitors - MarketWatch
symbol__ Stock Quote Price and Forecast - CNN
Baxter International (NY: BAX - FinancialContent
Why Baxter (BAX) Shares Are Sliding Today - Yahoo Finance
Baxter International Inc.: - marketscreener.com
Citi Downgrades Baxter International Inc(BAX.US) to Sell Rating, Cuts Target Price to $17 - Moomoo
Citigroup Downgrades Baxter International to Sell From Neutral, Adjusts PT to $17 From $19 - Moomoo
Baxter International Inc To Go Ex-Dividend On May 29th, 2026 With 0.01 USD Dividend Per Share - 富途牛牛
Baxter International Stock Surges 12%, With A 6-Day Winning Spree - Trefis
Baxter International Stock 6-Day Winning Spree: Stock Climbs 12% - Trefis
Baxter International Inc. (BAX) Stock Analysis: Navigating Healthcare’s Dynamic Terrain with 15% Upside Potential - DirectorsTalk Interviews
Has Baxter International (BAX) Overreacted After Recent 10.9% Weekly Share Price Jump - Yahoo Finance
Baxter Stock Logs Worst Day In 3 Months On Margin Pain And Weak Guidance — Retail Sees Long-Term Buy Opportunity - MSN
5-Day Rally Sends Baxter International Stock Up 11% - Trefis
Baxter International Stock 5-Day Winning Spree: Stock Climbs 11% - Trefis
Baxter International Inc (BAX) Stock Price, Quote, News & History - Benzinga
Baxter Highlights Social, Economic and Environmental Performance in Seventh Annual Sustainability Report - CSRwire
Baxter Stock Is Testing a Bottom After Healthcare Sector Decimation - Yahoo Finance
Market Watch Rx: Baxter International Leads Gainers - Pharmaceutical Executive
Why Baxter Gains as Russell 1000 Index Healthcare Shift Trend? - Kalkine Media
Q1 Earnings Review: Medical Devices & SuppliesDiversified Stocks Led by Baxter (NYSE:BAX) - Yahoo Finance UK
Baxter International Inc. stock (US0673431090): spin-off hangover meets margin push - AD HOC NEWS
Baxter International earnings preview: What to expect - MSN
Baxter International shareholders approve board slate, pay and incentive plan at annual meeting - MSN
First Pacific Advisors's Baxter International Inc(BAX) Holding History - GuruFocus
Baxter International Inc. stock (US0673431090): governance changes and board size reset in focus - AD HOC NEWS
Baxter International Inc. stock (US0673431090): spin-off hangover meets restructuring push - AD HOC NEWS
Baxter International Inc (BAX) Stock Up 3.0% and Still Undervalued -- GF Score: 61/100 - GuruFocus
Baxter Board Size Reset Puts Governance Changes In Focus For Investors - simplywall.st
Baxter stock (US0673431090): FDA update puts focus on hospital-device demand - AD HOC NEWS
TD Cowen Maintains Baxter International Inc(BAX.US) With Hold Rating, Maintains Target Price $20 - Moomoo
BAX (NYSE: BAX) affiliate files notice listing prior open-market purchases - Stock Titan
Baxter International Inc. (BAX) Stock Analysis: Exploring a 27.83% Potential Upside Amidst Healthcare Sector Dynamics - DirectorsTalk Interviews
Is Baxter International (BAX) Pricing Reflect A Turn After Steep Multi Year Share Price Declines - Sahm
Baxter hosts manufacturing forum - Manufacturers' Monthly
Baxter International stock (US0673431090): News flow turns after fresh market moves - AD HOC NEWS
Baxter International stock (US0718131099): Q1 update highlights mixed sales and margin pressure - AD HOC NEWS
BofA Securities Maintains Baxter International Inc(BAX.US) With Hold Rating, Maintains Target Price $24 - Moomoo
Baxter International Inc. stock (US0673431090): pharma supplier in focus after latest price swings - AD HOC NEWS
Finanzdaten der Baxter International Inc-Aktie (BAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.99%
1.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):